480 related articles for article (PubMed ID: 19825373)
41. N-hydroxy-7-(2-naphthylthio) heptanomide inhibits retinal and choroidal angiogenesis.
Kim JH; Kim JH; Oh M; Yu YS; Kim KW; Kwon HJ
Mol Pharm; 2009; 6(2):513-9. PubMed ID: 19718802
[TBL] [Abstract][Full Text] [Related]
42. Inhibitory effect of rapamycin on corneal neovascularization in vitro and in vivo.
Kwon YS; Hong HS; Kim JC; Shin JS; Son Y
Invest Ophthalmol Vis Sci; 2005 Feb; 46(2):454-60. PubMed ID: 15671269
[TBL] [Abstract][Full Text] [Related]
43. The influence of enamel matrix derivative on the angiogenic activity of primary endothelial cells.
Kasaj A; Meister J; Lehmann K; Stratul SI; Schlee M; Stein JM; Willershausen B; Schmidt M
J Periodontal Res; 2012 Aug; 47(4):479-87. PubMed ID: 22212171
[TBL] [Abstract][Full Text] [Related]
44. Anti-angiogenic effect of caffeic acid on retinal neovascularization.
Kim JH; Lee BJ; Kim JH; Yu YS; Kim KW
Vascul Pharmacol; 2009 Oct; 51(4):262-7. PubMed ID: 19589397
[TBL] [Abstract][Full Text] [Related]
45. Pleiotropic effects of YC-1 selectively inhibit pathological retinal neovascularization and promote physiological revascularization in a mouse model of oxygen-induced retinopathy.
DeNiro M; Al-Halafi A; Al-Mohanna FH; Alsmadi O; Al-Mohanna FA
Mol Pharmacol; 2010 Mar; 77(3):348-67. PubMed ID: 20008515
[TBL] [Abstract][Full Text] [Related]
46. Angiogenic role of adrenomedullin through activation of Akt, mitogen-activated protein kinase, and focal adhesion kinase in endothelial cells.
Kim W; Moon SO; Sung MJ; Kim SH; Lee S; So JN; Park SK
FASEB J; 2003 Oct; 17(13):1937-9. PubMed ID: 12897063
[TBL] [Abstract][Full Text] [Related]
47. A novel compound, NP-184, inhibits the vascular endothelial growth factor induced angiogenesis.
Lin KT; Lien JC; Chung CH; Kuo SC; Huang TF
Eur J Pharmacol; 2010 Mar; 630(1-3):53-60. PubMed ID: 20067787
[TBL] [Abstract][Full Text] [Related]
48. Therapeutic efficacy of a novel non-peptide αvβ3 integrin antagonist for pathological retinal angiogenesis in mice.
Li YJ; Li XH; Wang LF; Kuang X; Hang ZX; Deng Y; Du JR
Exp Eye Res; 2014 Dec; 129():119-26. PubMed ID: 25446322
[TBL] [Abstract][Full Text] [Related]
49. Isoliquiritigenin from licorice root suppressed neovascularisation in experimental ocular angiogenesis models.
Jhanji V; Liu H; Law K; Lee VY; Huang SF; Pang CP; Yam GH
Br J Ophthalmol; 2011 Sep; 95(9):1309-15. PubMed ID: 21719569
[TBL] [Abstract][Full Text] [Related]
50. β-LGND2, an ERβ selective agonist, inhibits pathologic retinal neovascularization.
Giddabasappa A; Eswaraka JR; Barrett CM; Bauler MN; Wu Z; Yepuru M; Miller DD; Dalton JT
Invest Ophthalmol Vis Sci; 2012 Jul; 53(8):5066-75. PubMed ID: 22714897
[TBL] [Abstract][Full Text] [Related]
51. Phosphatidylinositol inhibits vascular endothelial growth factor-A--induced migration of human umbilical vein endothelial cells.
Matsunaga N; Shimazawa M; Otsubo K; Hara H
J Pharmacol Sci; 2008 Jan; 106(1):128-35. PubMed ID: 18187933
[TBL] [Abstract][Full Text] [Related]
52. Inhibition of ocular neovascularization by a novel peptide derived from human placenta growth factor-1.
Zheng Y; Gu Q; Xu X
Acta Ophthalmol; 2012 Nov; 90(7):e512-23. PubMed ID: 22994140
[TBL] [Abstract][Full Text] [Related]
53. Targeting of integrin-linked kinase with small interfering RNA inhibits VEGF-induced angiogenesis in retinal endothelial cells.
Xie W; Zhao M; Zhou W; Guo L; Huang L; Yu W; Li X
Ophthalmic Res; 2013; 49(3):139-49. PubMed ID: 23258222
[TBL] [Abstract][Full Text] [Related]
54. New molecular mechanisms of the unexpectedly complex role of VEGF in ulcerative colitis.
Tolstanova G; Khomenko T; Deng X; Szabo S; Sandor Z
Biochem Biophys Res Commun; 2010 Sep; 399(4):613-6. PubMed ID: 20682292
[TBL] [Abstract][Full Text] [Related]
55. High glucose and elevated fatty acids suppress signaling by the endothelium protective ligand angiopoietin-1.
Singh H; Brindle NP; Zammit VA
Microvasc Res; 2010 Mar; 79(2):121-7. PubMed ID: 20079751
[TBL] [Abstract][Full Text] [Related]
56. Anti-angiogenic activity of carebastine: a plausible mechanism affecting airway remodelling.
De Luisi A; Mangialardi G; Ria R; Acuto G; Ribatti D; Vacca A
Eur Respir J; 2009 Oct; 34(4):958-66. PubMed ID: 19357149
[TBL] [Abstract][Full Text] [Related]
57. Aqueous extract of the medicinal plant Patrinia villosa Juss. induces angiogenesis via activation of focal adhesion kinase.
Jeon J; Lee J; Kim C; An Y; Choi C
Microvasc Res; 2010 Dec; 80(3):303-9. PubMed ID: 20594998
[TBL] [Abstract][Full Text] [Related]
58. BRN-103, a novel nicotinamide derivative, inhibits VEGF-induced angiogenesis and proliferation in human umbilical vein endothelial cells.
Choi HE; Yoo MS; Choi JH; Lee JY; Kim JH; Kim JH; Lee JK; Kim GI; Park Y; Chi YH; Paik SH; Lee JH; Lee KT
Bioorg Med Chem Lett; 2011 Nov; 21(21):6236-41. PubMed ID: 21963305
[TBL] [Abstract][Full Text] [Related]
59. Harmine inhibits tumour specific neo-vessel formation by regulating VEGF, MMP, TIMP and pro-inflammatory mediators both in vivo and in vitro.
Hamsa TP; Kuttan G
Eur J Pharmacol; 2010 Dec; 649(1-3):64-73. PubMed ID: 20858484
[TBL] [Abstract][Full Text] [Related]
60. Pigment epithelium-derived factor inhibits erythropoietin-induced retinal endothelial cell angiogenesis by suppression of PI3K/Akt pathway.
Haribalaganesh R; Sheikpranbabu S; Banumathi E; Gurunathan S
Exp Eye Res; 2010 Jun; 90(6):726-33. PubMed ID: 20298690
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
